08-08-2024 |
AH |
|
ADMA |
ADMA Biologics Inc |
2,750 |
0.13 |
0.08 |
-0.02 |
ADMA Biologics GAAP EPS of $0.13 beats by $0.05, revenue of $107.19M beats by $20.78M [8/8/2024 4:37 PM] |
15.96 |
3.78 (30.97%) |
14.99 |
2.80 (22.97%) |
3.06 - 16.64 |
11,958,290 |
3,520,000 |
235,289 |
|
|
09-05-2024 |
AH |
|
ADMA |
ADMA Biologics Inc |
1,580 |
0.08 |
0.05 |
-0.03 |
ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M [5/9/2024 4:23 PM] |
8.82 |
1.89 (27.34%) |
8.22 |
1.29 (18.61%) |
3.06 - 9.02 |
10,952,779 |
2,260,000 |
240,527 |
|
|
28-02-2024 |
AH |
|
ADMA |
ADMA Biologics |
1,189 |
0.04 |
0.02 |
0.00 |
ADMA Biologics GAAP EPS of -$0.08 misses by $0.11, revenue of $73.9M beats by $0.93M [2/28/2024 4:10 PM] |
5.36 |
-0.02 (-0.46%) |
5.31 |
-0.07 (-1.30%) |
2.94 - 5.72 |
5,087,435 |
2,110,000 |
14,858 |
|
|
08-11-2023 |
AH |
|
ADMA |
ADMA Biologics Inc |
816.41 |
0.01 |
-0.01 |
-0.08 |
ADMA Biologics GAAP EPS of $0.01, revenue of $67.3M beats by $5.17M [11/8/2023 4:11 PM] |
3.84 |
0.22 (6.08%) |
3.99 |
0.37 (10.22%) |
2.47 - 4.65 |
6,847,000 |
2,110,000 |
37,974 |
|
|
09-08-2023 |
AH |
|
ADMA |
ADMA Biologics Inc |
920.21 |
-0.02 |
-0.02 |
-0.07 |
ADMA Biologics GAAP EPS of -$0.03 in-line, revenue of $60.13M beats by $4.63M [8/9/2023 4:20 PM] |
4.29 |
0.23 (5.54%) |
4.18 |
0.12 (2.96%) |
1.99 - 4.64 |
9,828,844 |
1,640,000 |
3,582 |
|
|
10-05-2023 |
AH |
4:05 PM ET (May 10) |
ADMA |
ADMA Biologics Inc |
777.87 |
-0.03 |
-0.05 |
-0.10 |
ADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59M [5/10/2023 4:11 PM] |
3.96 |
0.40 (11.06%) |
3.90 |
0.33 (9.24%) |
1.43 - 4.03 |
8,197,139 |
1,890,000 |
69,415 |
|
|
23-03-2023 |
AH |
4:05 PM ET (Mar 23) |
ADMA |
ADMA Biologics Inc |
775.37 |
-0.06 |
-0.06 |
-0.09 |
ADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88M [3/23/2023 4:06 PM] |
3.29 |
0.18 (5.63%) |
3.33 |
0.22 (7.07%) |
1.43 - 3.98 |
3,276,373 |
3,360,000 |
48,695 |
|
|
09-11-2022 |
AH |
4:05 PM ET (Nov 9) |
ADMA |
ADMA Biologics Inc |
496.78 |
-0.08 |
-0.08 |
-0.13 |
ADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61M [11/9/2022 4:17 PM] |
3.14 |
0.67 (27.13%) |
2.74 |
0.27 (10.93%) |
1.17 - 3.19 |
14,402,406 |
2,100,000 |
26,062 |
|
|
10-08-2022 |
AH |
4:05 PM ET (Aug 10) |
ADMA |
ADMA Biologics Inc |
426.08 |
-0.07 |
-0.09 |
-0.15 |
ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M [8/10/2022 4:10 PM] |
2.22 |
0.10 (4.72%) |
2.15 |
0.03 (1.42%) |
1.01 - 2.48 |
6,248,891 |
1,600,000 |
19,110 |
|
|
11-05-2022 |
AH |
4:05 PM ET (May 11) |
ADMA |
ADMA Biologics Inc |
301.98 |
-0.10 |
-0.08 |
-0.16 |
ADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95M [5/11/2022 4:10 PM] |
1.68 |
0.25 (17.48%) |
1.41 |
-0.02 (-1.40%) |
1.01 - 2.15 |
3,668,542 |
3,440,000 |
13,183 |
|
|
24-03-2022 |
AH |
4:00 PM ET (Mar 24) |
ADMA |
ADMA Biologics Inc |
313.30 |
-0.09 |
-0.10 |
-0.20 |
ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M [3/24/2022 4:19 PM] |
1.62 |
0.12 (8.33%) |
1.52 |
0.02 (1.33%) |
1.01 - 2.63 |
5,288,862 |
2,019,253 |
280,408 |
|
|
10-11-2021 |
AH |
4:05 PM ET (Nov 10) |
ADMA |
ADMA Biologics Inc |
266.31 |
-0.13 |
-0.15 |
-0.19 |
ADMA Biologics EPS beats by $0.01, beats on revenue [11/10/2021 4:10 PM] |
1.58 |
0.18 (12.86%) |
1.50 |
0.10 (7.14%) |
1.01 - 3.11 |
11,638,631 |
2,190,000 |
1,005,438 |
|
|
11-08-2021 |
AH |
4:05 PM ET (Aug 11) |
ADMA |
ADMA Biologics Inc |
202.54 |
-0.15 |
-0.15 |
-0.23 |
ADMA Biologics EPS beats by $0.01, beats on revenue [8/11/2021 4:18 PM] |
1.50 |
-0.03 (-1.96%) |
1.59 |
0.06 (3.92%) |
1.38 - 3.71 |
1,324,835 |
770,000 |
45,474 |
|
|
12-05-2021 |
AH |
4:05 PM ET (May 12) |
ADMA |
ADMA Biologics Inc |
214.10 |
-0.16 |
-0.17 |
-0.26 |
ADMA Biologics EPS beats by $0.01, beats on revenue [5/12/2021 4:07 PM] |
1.62 |
-0.05 (-2.99%) |
1.71 |
0.04 (2.40%) |
1.45 - 4.20 |
3,787,179 |
5,530,000 |
24,756 |
|
|
25-03-2021 |
AH |
4:05 PM ET (Mar 25) |
ADMA |
ADMA Biologics Inc |
196.66 |
-0.20 |
-0.17 |
-0.18 |
ADMA Biologics EPS misses by $0.02, beats on revenue [3/25/2021 4:08 PM] |
1.80 |
-0.25 (-12.20%) |
1.95 |
-0.10 (-4.88%) |
1.73 - 4.20 |
5,703,861 |
2,950,000 |
91,132 |
|
|
05-11-2020 |
AH |
4:05 PM ET (Nov 5) |
ADMA |
ADMA Biologics Inc |
179.61 |
-0.19 |
-0.20 |
-0.19 |
ADMA Biologics EPS beats by $0.01, beats on revenue [11/5/2020 4:37 PM] |
1.90 |
-0.20 (-9.72%) |
2.06 |
-0.05 (-2.37%) |
1.45 - 5.23 |
5,997,754 |
1,690,095 |
208,604 |
|
|
06-05-2020 |
AH |
|
ADMA |
ADMA Biologics Inc |
271.12 |
-0.26 |
-0.13 |
-0.31 |
|
0.0 |
0.0 (0.00%) |
0.0 |
0.0 (0.00%) |
0.0 - 0.0 |
0 |
0 |
0 |
|
|